丁酸梭菌辅助抗生素治疗肺部疾病
摘要
关键词
全文:
PDF参考
LEVIN, B. J., et al., A prominent glycyl radical enzyme in human gut microbiomes metabolizestrans-4-hydroxy-l-proline[J]. Science 355.6325 (2017): eaai8386.
STANLEY D, MASON L J, MACKIN K E, et al. Translocation and dissemination of commensalbacteria in post-stroke infection[J]. Nat Med, 2016,22(11):1277-1284.
曹佳绮,张明,何骞,等.益生菌丁酸梭菌防治肺部疾病的研究进展[J].中国医院药学杂志,2023,43(21):2448-2452.
陈伦圣,李志波,尚宝明,等.亚胺培南西司他丁钠和美罗培南应用于重症肺部感染的治疗成本效果分析[J].贵州医药,2019,43(2):233-236.
STOEVA M K, GARCIA-SO J, JUSTICE N, et al. Butyrate-producing human gut symbiont, Clostridium butyricum, and its role in health and disease[J]. Gut microbes, 2021,13(1):1-28.
王红霞.美罗培南与亚胺培南/西司他汀治疗重度呼吸道感染的效果比较[J].实用临床医药杂志,2018,22(23):125-127.
李莉.头孢哌酮钠舒巴坦钠治疗下呼吸道感染的临床疗效观察[J].生物磁学,2005,5(2):18-19.
江玉琨,陈志婷.西药药剂头孢哌酮钠舒巴坦钠的临床应用效果评价[J].滁州职业技术学院学报,2023,22(2):68-70.
TIAN P, YANG W, GUO X, et al. Early life gut microbiota sustains liver-resident natural killer cells maturation via the butyrate-IL-18 axis[J]. Nature communications, 2023,14(1):1710.
GRAY J, OEHRLE K, WORTHEN G, et al. Intestinal commensal bacteria mediate lung mucosal immunity and promote resistance of newborn mice to infection[J]. Sci Transl Med, 2017,9(376).
李皓琳,朱朝艳.头孢哌酮钠舒巴坦钠引起凝血功能异常的病例报告分析[J].海峡药学,2019,31(11):259-262.
WYPYCH, TOMASZ P., LAKSHANIE C. WICKRAMASINGHE, BENJAMIN J. MARALAND. The influence of the microbiome on respiratory health[J]. Nature immunology 20.10 (2019):1279-1290.
吕慧,饶早莼.美罗培南及万古霉素在肺部感染治疗中应用效果及安全性分析[J].黑龙江医药,2022,35(4):827-830.
SPATZ M, DA C G, VENTIN-HOLMBERG R, et al. Antibiotic treatment using amoxicillin-clavulanic acid impairs gut mycobiota development through modification of the bacterial ecosystem[J]. Microbiome, 2023,11(1):73.
DOI: http://dx.doi.org/10.12345/yzlcyxzz.v7i3.16242
Refbacks
- 当前没有refback。
此作品已接受知识共享署名-非商业性使用 4.0国际许可协议的许可。